search
NASDAQ
The Nasdaq building on Times Square in New York (littleny, iStock by Getty Images)
From the WebJuly 22, 2019, 4:33 pm
Intec Pharma tanks on Nasdaq after Parkinson’s trial failure
Globes: The Israeli firm’s key product — a delayed-release pill to treat advanced Parkinson’s — didn’t demonstrate better performance over existing drugs
The Nasdaq building on Times Square in New York (littleny, iStock by Getty Images)
From the WebJune 3, 2019, 3:38 pm
Medical aesthetic devices manufacturer InMode gearing up for Nasdaq IPO
Calcalist: The Israel-based firm is seeking to raise some $100 million at a company valuation of $400 million to $500 million, two people familiar with the matter say
A Brainsway device in action. (photo credit: courtesy)
From the WebApril 23, 2019, 4:00 pm
Brainsway completes Nasdaq IPO with $27.5 million
Calcalist: The Israeli firm that develops headsets to treat brain disorders by using magnetic stimulation is now dually listed in Tel Aviv and on the Nasdaq
Gamida Cell's lab manager Noga Goudsmid-Rosenheimer at work, July 16, 2017 (Shoshanna Solomon/Times of Israel)
From the WebOctober 28, 2018, 3:49 pm
Gamida cell downprices shares to raise $50 million in Nasdaq IPO
Jerusalem-based firm develops therapies for rare blood genetic conditions, like sickle cell anemia and cancers
An example of a profile page on Fiverr (Courtesy)
August 28, 2018, 1:22 pm
Freelance work marketplace Fiverr said to be seeking IPO at $1 billion valuation
Company officials have met with potential Wall Street underwriters for share offering by start of 2019, TheMarker financial daily reports
By Shoshanna Solomon
The Nasdaq building on Times Square in New York (littleny, iStock by Getty Images)
From the WebJuly 24, 2018, 1:08 pm
Gastro treatment firm RedHill wants to raise $117 on Nasdaq
Calcalist: RedHill’s treatment for Crohn’s disease is currently in phase 3 trials; results of the trial are expected in coming weeks
The Nasdaq building on Times Square in New York (littleny, iStock by Getty Images)
From the WebJuly 1, 2018, 1:26 pm
Israel drugmaker Entera Bio holds shares IPO on Nasdaq
Calcalist: Biomed company Entera Bio Ltd., which is developing a way to deliver large, molecule-based drugs orally, listed its shares on Nasdaq on Thursday
Pinchas Landau
March 25, 2018, 7:57 pm
Pinchas Landau
Yes, the looming global market crash affects you
The seemingly endless flow of cash for high-tech is about to evaporate: the party’s over for everyone
The Nasdaq building on Times Square in New York (littleny, iStock by Getty Images)
From the WebMarch 14, 2018, 9:29 am
Five Israeli companies are planning IPOs in 2018, says Nasdaq president
Calcalist: With 70 companies listed on the exchange today, Israel ranks third in Nasdaq listings, after the U.S. and China
Motus GI Pure-Vu system allows physicians to clean poorly prepped colons during a colonoscopy procedure (YouTube Screenshot)
From the WebFebruary 20, 2018, 4:49 pm
Enema startup Motus GI closes Nasdaq IPO at $17.5 million
Calcalist: The company, which has developed a medical device to help clean colons before procedures, filed for an IPO in January hoping to raise $28.8 million
Motus GI Pure-Vu system allows physicians to clean poorly prepped colons during a colonoscopy procedure (YouTube Screenshot)
January 7, 2018, 4:26 pm
Israel medical devices startup Motus files for Nasdaq IPO
Motus, whose system allows physicians to clean poorly prepared colons during colonoscopy procedures, to raise up to $28.8 million
By Shoshanna Solomon
Kaltura's video design platform interface (Photo credit: Courtesy)
November 1, 2017, 1:29 pm
Israel-founded Kaltura said to be eyeing Nasdaq IPO in 2018
Video software startup is gearing up for IPO at a valuation of $1 billion, Calcalist reports
By Shoshanna Solomon
Tel Aviv University's website, seen here attacked by anti-Israeli hackers, February 2012 (Photo credit: Courtesy TAU)
October 3, 2017, 4:42 pm
US-Israeli cybersecurity firm ForeScout files for Nasdaq IPO
Prospectus targets a $100 million IPO goal for the Tel Aviv and Silicon Valley-based company
By Shoshanna Solomon
Ziv Aviram, President and CEO of Mobileye, speaks at a conference at the Waldorf Astoria hotel in Jerusalem, November 23, 2016. (Miriam Alster/Flash90)
March 13, 2017, 4:06 pm
Mobileye to stay centered in Israel after buyout, will lead Intel work on driverless car
After Intel agrees to pay $15.3b for firm, Ziv Amiram says it will create world development center here, be responsible for self-driving vehicles on Intel‘s behalf
By Sue Surkes
Illustration of the Australian Securities Exchange (Courtesy ASX)
October 11, 2016, 11:31 am
Australian stock exchange to Israeli tech firms: Come list Down Under
6 Israeli companies offer shares on the ASX with another few in the pipeline, listings chief says as he prepares to woo more
By Shoshanna Solomon
Load More